Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
3680
Clinical Trial Start Date
2013
0Primary Completion Date
2013
0Study Completion Date
2013
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Prevention0
Intervention Type
Biological0
Interventional Trial Phase
Phase 40
Official Name
A Study to Evaluate the Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine0
Last Updated
October 16, 2013
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Other attributes
Intervention Treatment
Live Attenuated Varicella Vaccine0
Study summary
The purpose of this study is to observe the occurrence of adverse events, seroconversion rate and geometric mean titres(GMTs) of 2 doses of live attenuated varicella vaccine.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
